Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-014798
Filing Date
2022-03-02
Accepted
2022-03-02 16:50:34
Documents
2
Period of Report
2022-03-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4128
2 POA DOCUMENT poa.txt EX-24 3322
  Complete submission text file 0001209191-22-014798.txt   8835
Mailing Address 50 HAMPSHIRE STREET SUITE 401 CAMBRIDGE MA 02139
Business Address 50 HAMPSHIRE STREET SUITE 401 CAMBRIDGE MA 02139 857-320-6400
Oncorus, Inc. (Issuer) CIK: 0001671818 (see all company filings)

EIN.: 473779757 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ONCORUS, INC. 50 HAMPSHIRE STREET, SUITE 401 CAMBRIDGE MA 02139
Business Address
Goldberg John Mayer (Reporting) CIK: 0001826549 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39575 | Film No.: 22704514